Cargando…

m(6)A Regulator Expression Segregates Meningiomas Into Biologically Distinct Subtypes

BACKGROUND: Meningiomas are the most common primary intracranial tumors in adults. According to the 2021 World Health Organization (WHO) classification of central nervous system tumors, approximately 80% of meningiomas are WHO grade 1, that is, histopathologically benign, whereas about 20% are WHO g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jiawei, Sun, Shuchen, Ren, Leihao, Hua, Lingyang, Wang, Daijun, Xie, Qing, Wirsching, Hans-Georg, Deng, Jiaojiao, Weller, Michael, Gong, Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727752/ https://www.ncbi.nlm.nih.gov/pubmed/35004283 http://dx.doi.org/10.3389/fonc.2021.760892

Ejemplares similares

Application of MRI-Based Radiomics in Preoperative Prediction of NF2 Alteration in Intracranial Meningiomas
por: Sun, Shuchen, et al.
Publicado: (2022)

TERT Alterations Predict Tumor Progression in De Novo High-Grade Meningiomas Following Adjuvant Radiotherapy
por: Deng, Jiaojiao, et al.
Publicado: (2021)

Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma
por: Wang, Daijun, et al.
Publicado: (2020)

High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma
por: Hua, Lingyang, et al.
Publicado: (2020)

LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway
por: Ding, Yaodong, et al.
Publicado: (2022)

The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutations
por: Deng, Jiaojiao, et al.
Publicado: (2020)

A prognostic model for tumor recurrence and progression after meningioma surgery: preselection for further molecular work-up
por: Padevit, Luis, et al.
Publicado: (2023)

The Diagnostic Value Of Using (18)F-Fluorodeoxyglucose Positron Emission Tomography To Differentiate Between Low- And High-Grade Meningioma
por: Hua, Lingyang, et al.
Publicado: (2019)

The Preferred Locations of Meningioma According to Different Biological Characteristics Based on Voxel-Wise Analysis
por: Sun, Chongran, et al.
Publicado: (2020)

Two predominant molecular subtypes of spinal meningioma: thoracic NF2-mutant tumors strongly associated with female sex, and cervical AKT1-mutant tumors originating ventral to the spinal cord
por: Hua, Lingyang, et al.
Publicado: (2022)

Review of Atypical and Anaplastic Meningiomas: Classification, Molecular Biology, and Management
por: Wilson, Taylor Anne, et al.
Publicado: (2020)

Spinal meningiomas, from biology to management - A literature review
por: Serratrice, Nicolas, et al.
Publicado: (2023)

Angiogenic Gene Signature Derived from Subtype Specific Cell Models Segregate Proneural and Mesenchymal Glioblastoma
por: Sharma, Aman, et al.
Publicado: (2017)

Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma
por: Zhu, Hongda, et al.
Publicado: (2019)

Unraveling tumor microenvironment heterogeneity in malignant pleural mesothelioma identifies biologically distinct immune subtypes enabling prognosis determination
por: Yang, Kaidi, et al.
Publicado: (2022)

Gene Expression Signatures Identify Biologically Homogenous Subgroups of Grade 2 Meningiomas
por: Zador, Zsolt, et al.
Publicado: (2020)

Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits
por: Zhu, Yinjie, et al.
Publicado: (2023)

Analysis of Gene Expression Profiling in Meningioma: Deregulated Signaling Pathways Associated with Meningioma and EGFL6 Overexpression in Benign Meningioma Tissue and Serum
por: Wang, Xuanchun, et al.
Publicado: (2012)

Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial
por: Vils, Alex, et al.
Publicado: (2021)

An Overview of Managements in Meningiomas
por: Zhao, Lianhua, et al.
Publicado: (2020)

Identification of Distinct Immune Subtypes in Colorectal Cancer Based on the Stromal Compartment
por: Shen, Rongfang, et al.
Publicado: (2020)

Accurate Preoperative Distinction of Intracranial Hemangiopericytoma From Meningioma Using a Multihabitat and Multisequence-Based Radiomics Diagnostic Technique
por: Wei, Jingwei, et al.
Publicado: (2020)

Factors Related to the Post-operative Recurrence of Atypical Meningiomas
por: Ye, Wu, et al.
Publicado: (2020)

Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma
por: Wu, Wei, et al.
Publicado: (2020)

BPTF promotes the progression of distinct subtypes of breast cancer and is a therapeutic target
por: Bezrookove, Vladimir, et al.
Publicado: (2022)

Corrigendum: An Overview of Managements in Meningiomas
por: Zhao, Lianhua, et al.
Publicado: (2020)

Recent Advances in Meningioma Immunogenetics
por: Al-Rashed, May, et al.
Publicado: (2020)

Identification and Management of Aggressive Meningiomas
por: Patel, Bhuvic, et al.
Publicado: (2022)

Molecular determinants of outcomes in meningiomas
por: Lynes, John, et al.
Publicado: (2022)

Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma
por: Wirsching, Hans-Georg, et al.
Publicado: (2021)

Anterior Clinoidal Meningiomas: Meningeal Anatomical Considerations and Surgical Implications
por: Xu, Tao, et al.
Publicado: (2020)

Two Distinct Subtypes Revealed in Blood Transcriptome of Breast Cancer Patients With an Unsupervised Analysis
por: Ming, Wenlong, et al.
Publicado: (2019)

Analysis of Autophagy-Related Signatures Identified Two Distinct Subtypes for Evaluating the Tumor Immune Microenvironment and Predicting Prognosis in Ovarian Cancer
por: Chen, Xingyu, et al.
Publicado: (2021)

Lipomatous meningioma: A rare subtype of benign metaplastic meningiomas
por: Yüksel, Mehmet Onur, et al.
Publicado: (2017)

Molecular Mechanism and Approach in Progression of Meningioma
por: Shao, Zhiwei, et al.
Publicado: (2020)

Corrigendum: Identification and management of aggressive meningiomas
por: Patel, Bhuvic, et al.
Publicado: (2022)

Recent advances in the molecular prognostication of meningiomas
por: Wang, Elaina J., et al.
Publicado: (2023)

Malignant Progression Contributes to the Failure of Combination Therapy for Atypical Meningiomas
por: Zhang, Qing, et al.
Publicado: (2021)

An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
por: Zhang, Dong, et al.
Publicado: (2023)

Transcriptomic Analysis Identified Two Subtypes of Brain Tumor Characterized by Distinct Immune Infiltration and Prognosis
por: Shen, Xilin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jlpdmbafq3h3qh93gcvtch1iqf